Back
Protagonist Therapeutics Vs. Barnes Group Industry Stock Comparison
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
44.34
Seasonality Move:
13.52%
Sell
45
B
Barnes Group
Last Price:
45.25
Seasonality Move:
3.08%
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.37. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Barnes Group (B)
is a Sell
Is Barnes Group a Buy, Sell or Hold?
- The current Barnes Group [B] share price is $45.26. The Score for B is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- B is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.37
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
B Stock Price Chart
What is Barnes Group's stock price today?
-
The Barnes Group share price today is $45.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and B is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 51.2 | Buy |
| Chaikin Money Flow: | -191605 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.06 - 46.3) | Sell |
| Bollinger Bands (100): | (32.41 - 43.17) | Buy |
B Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 72.17 | Buy |
| Chaikin Money Flow: | 1851639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.63 - 40.71) | Buy |
| Bollinger Bands (100): | (37.57 - 41.39) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.83 | Sell |
| 20-day SMA: | 45.37 | Sell |
| 50-day SMA: | 42.21 | Buy |
| 200-day SMA: | 32.24 | Buy |
| 8-day EMA: | 44.81 | Sell |
| 20-day EMA: | 44.61 | Sell |
| 50-day EMA: | 42.28 | Buy |
| 200-day EMA: | 33.58 | Buy |
B Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.31 | Buy |
| 20-day SMA: | 38.78 | Buy |
| 50-day SMA: | 38.65 | Buy |
| 200-day SMA: | 37.09 | Buy |
| 8-day EMA: | 40.79 | Buy |
| 20-day EMA: | 39.61 | Buy |
| 50-day EMA: | 39.13 | Buy |
| 200-day EMA: | 37.72 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Barnes Group Earnings Growth & B Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.47 per share.
Protagonist Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Barnes Group Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||